Long-term benefit of dobutamine in patients with congestive cardiomyopathy

American Heart Journal

Volumn 100, Issue 5, 1980, Pages 622-630

  Unverferth, Donald V ^a   Magorien, Raymond D ^a   Lewis, Richard P ^a   Leier, Carl V ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; LONG ACTING DRUG;

CONGESTIVE CARDIOMYOPATHY; ECHOCARDIOGRAPHY; HEART; HEART LEFT VENTRICLE PERFORMANCE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; SYSTOLIC TIME INTERVAL;

EID: 0019193313     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-8703(80)90226-4     Document Type: Article

References (34)

1. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility
2. Cardiac dynamic effects of increasing myocardial contractility without changing heart rate, mean aortic pressures and end diastolic volume in conscious instrumented dogs
3. Effects of Dobutamine on left ventricular performance, coronary dynamics and distribution of cardiac output in conscious dogs
4. In vivo analysis of adrenergic receptor activity of Dobutamine
5. Clinical cardiovascular pharmacology of dobutamine
6. Hemodynamic effects of a new inotropic agent (dobutamine) in chronic cardiac failure
7. Hemodynamic effects of dobutamine in patients with severe heart failure
8. The cardiovascular effects of the continous infusion of dobutamine in patients with severe heart failure
9. Alcoholic cardiomyopathy managed with prolonged bed rest
10. The effect of prolonged bed rest on postpartal cardiomyopathy
11. Idiopathic myocardiopathy of the puerperium (postpartal heart disease)
12. Value of prolonged bed rest in management of cardiomyopathy
13. Peripartum cardiomyopathy
14. Maternity and myocardial failure in African women
15. Effect of ethanol infusion on the ultrastructure of human myocardium
16. Idiopathic heart disease 1. Analysis of 100 cases with special reference to chronic alcoholism
17. Alcoholic cardiomyopathy, an electron microscopic study
18. Myocardial lesions in idiopathic and alcoholic cardiomyopathy
19. Reversibility of mitochondrial and contractile changes in the myocardium after cessation of prolonged ethanol intake
20. Vasodilator therapy—a physiologic approach to the treatment of heart failure
21. Hospital treatment of congestive heart failure. Management according to hemodynamic profile
22. Vasodilator therapy of cardiac failure
23. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure
24. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate
25. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise
26. Hemodynamic responsiveness to short and long acting vasodilators in left ventricular failure
27. Oral vasodilator therapy for chronic heart failure: a plea for caution
28. Symposium perspective
29. New and traditional therapy of congestive heart failure. A European view
30. Primary myocardial disease, A prospective clinical and hemodynamic evaluation in 100 patients
31. Beta-adrenergic receptors in coronary and skeletal muscle arteries
32. Response of the rabbit coronary arteries to autonomic agents